Tissue microarrays

BioTechniques

Volumn 36, Issue 1, 2004, Pages 98-105

  Simon, Ronald ^a   Mirlacher, Martina ^a   Sauter, Guido ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; COST EFFECTIVENESS; GENES; STATISTICAL METHODS; TISSUE;

MICROARRAYS;

BIOTECHNOLOGY;

COST EFFECTIVENESS ANALYSIS; DNA MICROARRAY; HUMAN; MEDICAL RESEARCH; REVIEW; TECHNOLOGY; TISSUE MICROARRAY;

EID: 0347285413     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/04361rv01     Document Type: Review

References (70)

1. Belin, D. 1998. The use of RNA probes for the analysis of gene expression. Northern blot hybridization and ribonuclease protection assay. Methods Mol. Biol. 86:87-102.
2. Kallioniemi, O.P. 2001. Biochip technologies in cancer research. Ann. Med. 33:142-147.
3. Bichsel, V.E., L.A. Liotta, and E.F. Petricoin, 3rd. 2001. Cancer proteomics: from biomarker discovery to signal pathway profiling. Cancer 17:69-78.
4. Walker, N.J. 2001. Real-time and quantitative PCR: applications to mechanism-based toxicology. J. Biochem. Mol. Toxicol. 15: 121-127.
5. Kononen, J., L. Bubendorf, A. Kallioniemi, M. Bärlund, P. Schraml, S. Leighton, J. Torhorst, M. Mihatsch, et al. 1998. Tissue microarrays for high-throughput molecular profiling of hundreds of specimens. Nat. Med. 4:844-847.
6. Simon, R., M. Mirlacher, and G. Sauter. 2003. Tissue microarrays in cancer diagnosis. Expert Rev. Mol. Diagn. 3:421-430.
7. Bubendorf, L., A. Nocito, H. Moch, and G. Sauter. 2001. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J. Pathol. 195:72-79.
8. Battifora, H. 1986. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab. Invest. 55: 244-248.
9. Wan, W.H., M.B. Fortuna, and P. Furmanski. 1987. A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J. Immunol. Methods 103:121-129.
10. Liu, C.L., W. Prapong, Y. Natkunam, A. Alizadeh, K. Montgomery, C.B. Gilks, and M. van de Rijn. 2002. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am. J. Pathol. 161: 1557-1565.
11. Fejzo, M.S. and D.J. Slamon. 2001. Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. Am. J. Pathol. 159:1645-1650.
12. Simon, R. and G. Sauter. 2002. Tissue microarrays for miniaturized high-throughput molecular profiling of tumors. Exp. Hematol. 30:1365-1372.
13. Garcia, J.F., F.I. Camacho, M. Morente, M. Fraga, C. Montalban, T. Alavaro, C. Bellas, A. Castano, et al. 2002. Hodgkin's and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue-microarrays. Blood 12:681-689.
14. Hedvat, C.V., A. Hegde, R.S. Chaganti, B. Chen, J. Qin, D.A. Filippa, S.D. Nimer, and J. Teruya-Feldstein. 2002. Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma. Hum. Pathol. 33:968-974.
15. Tzankov, A., A. Zimpfer, A. Lugli, J. Krugmann, P. Went, P. Schraml, R. Maurer, S. Ascani, et al. 2003. High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1. J. Pathol. 199: 201-207.
16. Yosepovich, A. and J. Kopolovic. 2002. Tissue microarray technology - a new and powerful tool for the molecular profiling of tumors. Harefuah 141:1039-1041.
17. Hendriks, Y., P. Franken, J.W. Dierssen, W. De Leeuw, J. Wijnen, E. Dreef, C. Tops, M. Breuning, et al. 2003. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am. J. Pathol. 162:469-477.
18. Ginestier, C., E. Charafe-Jauffret, F. Bertucci, F. Eisinger, J. Geneix, D. Bechlian, N. Conte, J. Adelaide, et al. 2002. Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. Am. J. Pathol. 161: 1223-1233.
19. Camp, R.L., L.A. Charette, and D.L. Rimm. 2000. Validation of tissue microarray technology in breast carcinoma. Lab. Invest. 80:1943-1949.
20. Moch, H., P. Schraml, L. Bubendorf, M. Mirlacher, J. Kononen, T. Gasser, M.J. Mihatsch, O.P. Kallioniemi, et al. 1999. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am. J. Pathol. 154:981-986.
21. Nocito, A., L. Bubendorf, E.M. Tinner, K. Suess, U. Wagner, T. Forster, J. Kononen, A. Fijan, et al. 2001. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J. Pathol. 194:349-357.
22. Torhorst, J., C. Bucher, J. Kononen, P. Haas, M. Zuber, O.R. Kochli, F. Mross, H. Dieterich, et al. 2001. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am. J. Pathol. 159:2249-2256.
23. Rassidakis, G.Z., D. Jones, A. Thomaides, F. Sen, R. Lai, F. Cabanillas, T.J. McDonnell, and L.J. Medeiros. 2002. Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections. Am. J. Clin. Pathol. 118: 328-334.
24. Hoos, A., M.J. Urist, A. Stojadinovic, S. Mastorides, M.E. Dudas, D.H. Leung, D. Kuo, M.F. Brennan, et al. 2001. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am. J. Pathol. 158:1245-1251.
25. Mucci, N.R., G. Akdas, S. Manely, and M.A. Rubin. 2000. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum. Pathol. 31:406-414.
26. Natkunam, Y., R.A. Warnke, K. Montgomery, B. Falini, and M. van De Rijn. 2001. Analysis of mum1/irf4 protein expression using tissue microarrays and immunohistochemistry. Mod. Pathol. 14:686-694.
27. Rubin, M.A., R. Dunn, M. Strawderman, and K.J. Pienta. 2002. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am. J. Surg. Pathol. 26: 312-319.
28. Sallinen, S.L., P.K. Sallinen, H.K. Haapasalo, H.J. Helin, P.T. Helen, P. Schraml, O.P. Kallioniemi, and J. Kononen. 2000. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res. 60:6617-6622.
29. Engellau, J., M. Akerman, H. Anderson, H.A. Domanski, E. Rambech, T.A. Alvegard, and M. Nilbert. 2001. Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma. Appl. Immunohistochem. Mol. Morphol. 9:358-363.
30. Gulmann, C., D. Butler, E. Kay, A. Grace, and M. Leader. 2003. Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 42:70-76.
31. Fernebro, E., M. Dictor, P.O. Bendahl, M. Ferno, and M. Nilbert. 2002. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch. Pathol. Lab. Med. 126:702-705.
32. Merseburger, A.S., M.A. Kuczyk, J. Serth, C. Bokemeyer, D.Y. Young, L. Sun, R.R. Connelly, D.G. McLeod, et al. 2003. Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. Oncol. Rep. 10:223-228.
33. Hoos, A., A. Stojadinovic, S. Mastorides, M.J. Urist, D. Polsky, C.J. Di Como, M.F. Brennan, and C. Cordon-Cardo. 2001. High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas. Cancer 92:869-874.
34. Hoos, A., A. Stojadinovic, B. Singh, M.E. Dudas, D.H. Leung, A.R. Shaha, J.P. Shah, M.F. Brennan, et al. 2002. Clinical significance of molecular expression profiles of Hurthle cell tumors of the thyroid gland analyzed via tissue microarrays. Am. J. Pathol. 160:175-183.
35. Barlund, M., F. Forozan, J. Kononen, L. Bubendorf, Y. Chen, M.L. Bittner, J. Torhorst, P. Haas, et al. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J. Natl. Cancer Inst. 92:1252-1259.
36. Schraml, P., J. Kononen, L. Bubendorf, H. Moch, H. Bissig, A. Nocito, M. Mihatsch, O. Kallioniemi, et al. 1999. Tissue microarrays for gene amplification surveys in many different tumor types. Clin. Cancer Res. 5: 1966-1975.
37. Andersen, C.L., O. Monni, U. Wagner, J. Kononen, M. Barlund, C. Bucher, P. Haas, A. Nocito, et al. 2002. High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays. Am. J. Pathol. 161:73-79.
38. Schraml, P., C. Bucher, H. Bissig, A. Nocito, P. Haas, K. Wilber, S. Seelig, J. Kononen, et al. 2003. Cyclin E overexpression and amplification in human tumours. J. Pathol. 200:375-382.
39. Packeisen, J., H. Buerger, R. Krech, and W. Boecker. 2002. Tissue microarrays: a new approach for quality control in immunohistochemistry. J. Clin. Pathol. 55:613-615.
40. Bubendorf, L., J. Kononen, P. Koivisto, P. Schraml, H. Moch, T.C. Gasser, N. Willi, M.J. Mihatsch, et al. 1999. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res. 59:803-806.
41. Richter, J., U. Wagner, J. Kononen, A. Fijan, J. Bruderer, U. Schmid, D. Ackermann, R. Maurer, et al. 2000. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am. J. Pathol. 157:787-794.
42. Simon, R., J. Richter, U. Wagner, A. Fijan, J. Bruderer, U. Schmid, D. Ackermann, R. Maurer, et al. 2001. High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res. 61:4514-4519.
43. Simon, R., K. Struckmann, P. Schraml, U. Wagner, T. Forster, H. Moch, A. Fijan, J. Bruderer, et al. 2002. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene 21: 2476-2483.
44. Kocher, T., M. Zheng, M. Bolli, R. Simon, T. Forster, E. Schultz-Thater, E. Remmel, C. Noppen, et al. 2002. Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study. Int. J. Cancer 100:702-705.
45. Park, S.Y., H.S. Kim, E.K. Hong, and W.H. Kim. 2002. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum. Pathol. 33:1078-1085.
46. Bubendorf, L., M. Kolmer, J. Kononen, P. Koivisto, S. Mousses, Y. Chen, E. Mahlamaki, P. Schraml, et al. 1999. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J. Natl. Cancer Inst. 91:1758-1764.
47. Saramaki, O., N. Willi, O. Bratt, T.C. Gasser, P. Koivisto, N.N. Nupponen, L. Bubendorf, and T. Visakorpi. 2001. Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer. Am. J. Pathol. 159: 2089-2094.
48. Rubin, M.A., N.R. Mucci, J. Figurski, A. Fecko, K.J. Pienta, and M.L. Day. 2001. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum. Pathol. 32:690-697.
49. Oka, T., T. Yoshino, K. Hayashi, N. Ohara, T. Nakanishi, Y. Yamaai, A. Hiraki, C.A. Sogawa, et al. 2001. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias: combination analysis with cDNA expression array and tissue microarray. Am. J. Pathol. 159:1495-1505.
50. Simon, R., A. Nocito, T. Hübscher, C. Bucher, J. Torhorst, P. Schraml, L. Bubendorf, M.J. Mihatsch, et al. 2001. Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. J. Natl. Cancer Inst. 93:1141-1146.
51. Rao, J., D. Seligson, H. Visapaa, S. Horvath, M. Eeva, K. Michel, A. Pantuck, A. Belldegrun, et al. 2002. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer 95:1247-1257.
52. Ristimaki, A., A. Sivula, J. Lundin, M. Lundin, T. Salminen, C. Haglund, H. Joensuu, and J. Isola. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 62:632-635.
53. Poremba, C., B. Heine, R. Diallo, A. Heinecke, D. Wai, K.L. Schaefer, Y. Braun, A. Schuck, et al. 2002. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J. Pathol. 198:181-189.
54. Perry, M.C., editor. 2000. Automated, high-throughput tissue microarray analysis for assessing the significance of HER-2 involvement in breast cancer. In Proceedings of the ASCO annual meeting, Abstr. No. 2388; 2000 May 20-23; New Orleans. Alexandria (VA): American Society of Clinical Oncology. 1 p.
55. Dhanasekaran, S.M., T.R. Barrette, D. Ghosh, R. Shah, S. Varambally, K. Kurachi, K.J. Pienta, M.A. Rubin, et al. 2001. Delineation of prognostic biomarkers in prostate cancer. Nature 412:822-826.
56. Mousses, S., L. Bubendorf, U. Wagner, G. Hostetter, J. Kononen, R. Cornelison, N. Goldberger, A.G. Elkahloun, et al. 2002. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res. 62:1256-1260.
57. Miettinen, H.E., T.A. Jarvinen, U. Kellner, P. Kauraniemi, R. Parwaresch, I. Rantala, H. Kalimo, L. Paljarvi, et al. 2000. High topoisomerase IIalpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas. Neuropathol. Appl. Neurobiol. 26:504-512.
58. Miettinen, H.E., N. Paunu, I. Rantala, H. Kalimo, L. Paljarvi, H. Helin, and H. Haapasalo. 2001. Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: a study by novel tumor microarray technique. J. Neurooncol. 55:29-37.
59. Wang, Y., M.C. Wu, J.S. Sham, W. Zhang, W.Q. Wu, and X.Y. Guan. 2002. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer 95:2346-2352.
60. Chung, G.G., E. Provost, E.P. Kielhorn, L.A. Charette, B.L. Smith, and D.L. Rimm. 2001. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis. Clin. Cancer Res. 7:4013-4020.
61. Hoos, A., A. Nissan, A. Stojadinovic, J. Shia, C.V. Hedvat, D.H. Leung, P.B. Paty, D. Klimstra, et al. 2002. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis. Clin. Cancer Res. 8:3841-3849.
62. Otsuka, M., M. Kato, T. Yoshikawa, H. Chen, E.J. Brown, Y. Masuho, M. Omata, and N. Seki. 2001. Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis. Biochem. Biophys. Res. Commun. 289:876-881.
63. Kielhorn, E., E. Provost, D. Olsen, T.G. D'Aquila, B.L. Smith, R.L. Camp, and D.L. Rimm. 2003. Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome. Int. J. Cancer 103:652-656.
64. Simon, R., R. Atefy, U. Wagner, T. Forster, A. Fijan, J. Bruderer, K. Wilber, M.J. Mihatsch, et al. 2003. HER-2 and TOP2A coamplification in urinary bladder cancer. Int. J. Cancer 107:764-772.
65. Hoos, A. and C. Cordon-Cardo. 2001. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab. Invest. 81:1331-1338.
66. Rao, J., D. Seligson, and G.P. Hemstreet. 2002. Protein expression analysis using quantitative fluorescence image analysis on tissue microarray slides. BioTechniques 32: 924-932.
67. Camp, R.L., G.G. Chung, and D.L. Rimm. 2002. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat. Med. 8:1323-1327.
68. Haedicke, W., H.H. Popper, C.R. Buck, and K. Zatloukal. 2003. Automated evaluation and normalization of immunohistochemistry on tissue microarrays with a DNA microarray scanner. BioTechniques 35:164-168.
69. Bova, G.S., G. Parmigiani, J.I. Epstein, T. Wheeler, N.R. Mucci, and M.A. Rubin. 2001. Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading. Hum. Pathol. 32:417-427.
70. Manley, S., N.R. Mucci, A.M. De Marzo, and M.A. Rubin. 2001. Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model. Am. J. Pathol. 159:837-843.